Shell Asset Management Co. Has $550,000 Holdings in Tenet Healthcare Corporation $THC

Shell Asset Management Co. decreased its stake in Tenet Healthcare Corporation (NYSE:THC) by 57.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,709 shares of the company’s stock after selling 3,702 shares during the period. Shell Asset Management Co.’s holdings in Tenet Healthcare were worth $550,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of THC. ProShare Advisors LLC increased its holdings in shares of Tenet Healthcare by 1.7% during the 2nd quarter. ProShare Advisors LLC now owns 4,118 shares of the company’s stock worth $725,000 after purchasing an additional 67 shares during the period. Quadcap Wealth Management LLC increased its stake in Tenet Healthcare by 1.7% during the second quarter. Quadcap Wealth Management LLC now owns 4,099 shares of the company’s stock valued at $721,000 after acquiring an additional 69 shares during the period. Andina Capital Management LLC lifted its position in shares of Tenet Healthcare by 2.1% in the 3rd quarter. Andina Capital Management LLC now owns 3,360 shares of the company’s stock worth $682,000 after acquiring an additional 69 shares during the period. Assetmark Inc. grew its holdings in shares of Tenet Healthcare by 0.9% during the 2nd quarter. Assetmark Inc. now owns 8,709 shares of the company’s stock worth $1,533,000 after purchasing an additional 76 shares in the last quarter. Finally, MGO One Seven LLC raised its stake in shares of Tenet Healthcare by 3.8% in the third quarter. MGO One Seven LLC now owns 2,231 shares of the company’s stock valued at $453,000 after purchasing an additional 82 shares in the last quarter. 95.44% of the stock is owned by institutional investors.

Tenet Healthcare Price Performance

Tenet Healthcare stock opened at $234.37 on Wednesday. Tenet Healthcare Corporation has a 52 week low of $109.82 and a 52 week high of $235.77. The firm has a market cap of $20.60 billion, a P/E ratio of 15.13, a P/E/G ratio of 0.96 and a beta of 1.44. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. The business’s fifty day moving average is $199.97 and its two-hundred day moving average is $196.22.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. The business had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The firm’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same period in the previous year, the business posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities research analysts forecast that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on THC shares. Morgan Stanley reissued an “overweight” rating and issued a $260.00 price target on shares of Tenet Healthcare in a report on Thursday, February 12th. Truist Financial increased their price target on shares of Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday. Barclays lifted their price objective on Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a report on Friday. Royal Bank Of Canada raised their target price on Tenet Healthcare from $253.00 to $277.00 and gave the stock an “outperform” rating in a research report on Thursday, February 12th. Finally, JPMorgan Chase & Co. upped their price target on Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $246.71.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the company’s stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. This represents a 7.10% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.81% of the stock is currently owned by corporate insiders.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.